Latest papers

Polyglutamine and polyalanine expansions in ataxin7 result in different types of aggregation and levels of toxicity

Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate.

Amyloid beta: the alternate hypothesis.

Inhibitory effect of minocycline on amyloid beta fibril formation and human microglial activation.

The role of cystatin C in cerebral amyloid angiopathy and stroke: cell biology and animal models.

[Advances in molecular pathology of Alzheimer's disease].

Effects of lipids and aging on the neurotoxicity and neuronal loss caused by intracerebral injections of the amyloid-beta peptide in the rat.

Non-steroidal anti-inflammatory drugs have anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro.

Exploring the early steps of amyloid peptide aggregation by computers.

Relationship between microtubule-binding repeats and morphology of neurofibrillary tangle in Alzheimer's disease.

Synthesis of 6-[2-(benzoxazol-2-ylmethylamino)ethoxy]-1-alkyl-1H-indole-2-carboxylic acid and inhibitory activity on beta-amyloid aggregation.

Aluminum-induced neurotoxicity and oxidative damage in rabbits: protective effect of melatonin.

Neurotrophic effect of magnolol in the hippocampal CA1 region of senescence-accelerated mice (SAMP1).

Identification of synaptic plasma membrane proteins co-precipitated with fibrillar beta-amyloid peptide.

Pharmacological approaches of neurofibrillary degeneration.

Protein quality control in Alzheimer's disease: a fatal saviour.

Acetylcholinesterase in Hirschsprung's disease.

Tau, tangles, and Alzheimer's disease

Tau pathology in Alzheimer disease and other tauopathies.

Recent advances in experimental modeling of the assembly of tau filaments